Skip to main content
Signal8

Deschamps Philippe

SEC insider (Form 3/4/5 filer). CIK 0001638231. Director at Coeptis Therapeutics Holdings, Inc. (COEP). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 11, 2026. Located in WEXFORD, PA.

Companies Deschamps Philippe has filed insider reports for

  • Coeptis Therapeutics Holdings, Inc. (COEP): Director
Deschamps Philippe profile photo

Deschamps Philippe

CIK: 0001638231

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Coeptis Therapeutics Holdings, Inc. logo
COEP

Coeptis Therapeutics Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Coeptis Therapeutics Holdings, Inc. logo
    COEP

    Coeptis Therapeutics Holdings, Inc.

    Feb 11, 2026
    Exercise
    Direct
    5.7K shares at avg. $10.56$60K
  • Coeptis Therapeutics Holdings, Inc. logo
    COEP

    Coeptis Therapeutics Holdings, Inc.

    Feb 11, 2026
    Award
    Direct
    3.3K shares-
  • Coeptis Therapeutics Holdings, Inc. logo
    COEP

    Coeptis Therapeutics Holdings, Inc.

    Mar 4, 2025
    Award

    Non-qualified Stock Options (right to buy)

    Direct
    5.7K shares-

1-3 of 3